Αποτελέσματα Αναζήτησης
10 Νοε 2021 · In children, seizures and cerebellar dysfunction have been reported with EFV use and the incidence of rash appears to be higher in children than adults. 19, 24 CNS side effects can be reduced if the dose is taken at bedtime on an empty stomach and following such specific dosing instruction could potentially be inconvenient to the patient or the ...
- HIV Treatment in Infants and Children
Studies undertaken by the NIAID-supported Pediatric AIDS...
- HIV Treatment in Infants and Children
29 Δεκ 2021 · Children with human immunodeficiency virus type 1 (HIV-1) infection have limited options for effective antiretroviral treatment (ART). We conducted an open-label, randomized, noninferiority...
18 Ιουλ 2022 · The HIV treatment landscape is evolving towards treatment regimens with fewer side-effects, greater tolerability, and potential for less frequent administration, and towards an increasing desire to promote alignment between drugs used for treatment and prevention of HIV.
16 Ιουν 2020 · On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments.
21 Ιουν 2023 · Data to inform the switch from a ritonavir-boosted protease inhibitor (PI) to dolutegravir in patients living with human immunodeficiency virus (HIV) infection who do not have genotype...
11 Απρ 2022 · • The Panel also noted that children with HIV who are relocating from outside the United States may benefit from thyroid function studies and additional evaluations, such as screening for tuberculosis, gastrointestinal parasites, hepatitis infection, and lead level.
Studies undertaken by the NIAID-supported Pediatric AIDS Clinical Trials Group (PACTG) found that, much like in adults, effective treatment for children living with HIV required a potent combination of antiretroviral drugs.